APA (7th ed.) Citation

R, S., M, M., A, S., B, B., CD, W., EC, C., . . . K, P. (2025). Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer. JCO precision oncology, 9, e2500332. https://doi.org/10.1200/PO-25-00332

Chicago Style (17th ed.) Citation

R, Surana, et al. "Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer." JCO Precision Oncology 9 (2025): e2500332. https://doi.org/10.1200/PO-25-00332.

MLA (9th ed.) Citation

R, Surana, et al. "Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer." JCO Precision Oncology, vol. 9, 2025, p. e2500332, https://doi.org/10.1200/PO-25-00332.